Nicheloom

Market intelligence for builders — see what's gaining traction before it's crowded.

Origin - Safer Cell & Gene Therapies with AI

AI designed regulatory DNA sequences to program gene expression patterns

Details

External ID
97480
Source
YC
Company
Origin
Product
Origin - Safer Cell & Gene Therapies with AI
Website domain
origin.bio
Launched
Feb. 4, 2026
Cohort
Winter 2026
Upvotes
18
Upvotes percentile
0.4186046511627907
Tags
AI-powered Drug Discovery, Artificial Intelligence, Biotech
Fetched at
Oct. 1, 2026, 1 a.m.
Updated at
Oct. 1, 2026, 1 a.m.

Enrichment

Theme
specialized AI models and agent reasoning tools
Vertical
Healthcare
Function
Agent / copilot
Audience
B2B
AI stance
AI-native
Project type
Commercial product
Normalized one-liner
ai-designed dna sequences for gene therapies
Manually corrected
False

Could you build this?

No Designing novel synthetic regulatory DNA sequences and modeling spatial transcriptomics requires wet-lab tissue profiling, proprietary biobank partnerships, and advanced computational biology models.

What it would actually take: The platform requires specialized wet-lab infrastructure to process FFPE tumor blocks, perform spatial transcriptomics, and conduct H&E imaging, combined with a high-performance bioinformatic pipeline. On top of that, deep generative sequence models (e.g., DNA language models and genomic diffusion models) must be trained to synthesize functional regulatory motifs. This requires multidisciplinary teams of molecular biologists, computational geneticists, and deep learning researchers with access to clinical biobanks.

Competitors

Other products that read as similar to this one — 437 launches clear the similarity bar, closest 8 shown.

Attention rank: #208 of 438 (itself plus its competitors, highest first — normalized so YC and Product Hunt are compared fairly).

Launched 96 days after the earliest competitor.

Other launches for this product

Same idea, different domain

Nobody's really built a agent / copilot tool for Agriculture yet.